0.634
0.32%
0.004
Precedente Chiudi:
$0.63
Aprire:
$0.6098
Volume 24 ore:
294.12K
Relative Volume:
0.25
Capitalizzazione di mercato:
$360.37K
Reddito:
$4.60M
Utile/perdita netta:
$-7.33M
Rapporto P/E:
0.0136
EPS:
46.49
Flusso di cassa netto:
$-13.42M
1 W Prestazione:
-2.60%
1M Prestazione:
-72.16%
6M Prestazione:
-94.55%
1 anno Prestazione:
-99.37%
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Nome
Tc Biopharm Holdings Plc Adr
Settore
Industria
Telefono
01414337557
Indirizzo
MAXIM 1, HOLYTOWN
Confronta TCBP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
TCBP | 0.632 | 360.37K | 4.60M | -7.33M | -13.42M | 46.49 |
VRTX | 448.45 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.78 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 587.26 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 247.71 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 106.50 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Tc Biopharm Holdings Plc Adr Borsa (TCBP) Ultime notizie
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
TC BioPharm secures European patent for cell therapy - Investing.com India
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm meets Nasdaq equity requirement - Investing.com
TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks
TC BioPharm secures $2 million in direct offering - Investing.com
TC Biopharm Announces Warrant Adjustment - TipRanks
TC Biopharm At Risk of Nasdaq Delisting - TipRanks
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Apple Hospitality REIT Inc (APLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
TC BioPharm adjusts ADS to ordinary share ratio - Investing.com
TC BioPharm Shareholders Approve Key Resolutions - TipRanks
Is TC BioPharm (Holdings) plc ADR (TCBP) worth investing in despite its overvalued state? – US Post News - US Post News
TC BioPharm Reschedules 2024 AGM for July - TipRanks
TC Biopharm Board Members Resign Suddenly - TipRanks
A year in review: TC BioPharm (Holdings) plc ADR (TCBP)'s performance in the last year – US Post News - US Post News
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer - The Globe and Mail
TC BioPharm Announces Pricing of $5.5 Million Public Offering - The Globe and Mail
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - The Globe and Mail
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead - The Globe and Mail
Market Highlights: TC BioPharm (Holdings) plc ADR (TCBP) Ends on a Low Note at 1.13 – DWinneX - The Dwinnex
TC BioPharm secures $3.1 million from warrant exercise By Investing.com - Investing.com
Amkor Technology stock rated overweight by JPMorgan, sees strong packaging demand By Investing.com - Investing.com
TC BioPharm eyes expansion with CAR-NK technology LOI - Investing.com
TC BioPharm aims to slash cancer treatment costs By Investing.com - Investing.com
Healthcare Stocks Making Moves Thursday: TCBP, DRRX, CLSD, XRTX, SPRB, IMRX, FWBI, RNXT - InvestorsObserver
symbol__ Stock Quote Price and Forecast - CNN
Healthcare Stocks Making Moves Monday: TCBP, BIAF, LXRX, GRPH, LTRN, OCEA, VTYX, SKYE - InvestorsObserver
TC BioPharm gains MHRA nod for trial amendment By Investing.com - Investing.com
TC Biopharm Plans Share Issuance, Calls Shareholder MeetingTipRanks.com - TipRanks
Healthcare Stocks Moving Up and Down Monday: RNLX, TTOO, CBAY, TLPH, ANTX, TCBP, IVVD, BDSX - InvestorsObserver
Tc Biopharm Holdings Plc Adr Azioni (TCBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):